Parkinson Disease

• CLINICAL_TRIALS trial_result · 2006-06-07
  Clinical Trial Update: Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease [Phase 3]

  Pfizer-sponsored Phase 3 trial evaluating Sumanirole for early Parkinson disease has completed.

• EMA withdrawal · 2006-05-23
  EMA Withdrawn: Daquiran (pramipexole dihydrochloride monohydrate) — Dr. Karl Thomae GmbH

  EMA withdrew Daquiran (pramipexole dihydrochloride monohydrate) from the market; Parkinson's disease was the therapeutic area.

• FDA approval · 2006-05-16
  FDA Approved: AZILECT — Original Application (Teva Neuroscience, Inc.)

  FDA approved AZILECT (rasagiline mesylate) as an original application from Teva Neuroscience for the treatment of Parkinson's disease.